Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Course Vonoprazan Test for Diagnosing GERD
ChiCTR2000039629Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vonoprazan in gastroesophageal reflux disease (GERD), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Sensitivity of the 4-week P-CAB test for diagnosis of GERD and Specificity of the 4-week P-CAB test for diagnosis of GERD (measured at week 2). Started Jan 2021; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ChiCTR2000039629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039629.